fda tirzepatide announcement US judge sides with FDA's removal of Lilly's weight loss drug from shortage list Tirzepatide, FDA, and Compounding: Understanding
Description
However, the timing can affect how you experience side effects
Here is an honest, research-backed timeline for what to expect when switching from semaglutide to tirzepatide
The question isn't whether semaglutide "works" it clearly does
The thigh offers a practical alternative for patients who prefer not to inject in the abdominal area or who have limited abdominal subcutaneous tissue
Any use beyond its approved indication is off-label and subject to provider evaluation
